Humacyte, Inc. insider trades
as of filings through Sep 15, 2026
- Bought
- $5,620
- 1 trade, 1 insider
- Sold
- $0
- 0 trades, 0 insiders
- Net
- +$5,620
- since Sep 15, 2026
- Under 10b5-1 plans
- 0
- of 0 sales
FiledStockInsiderSideValueSharesAvg priceTraded
- Filed Sep 15, 4:05 PM (the Form 4 at the SEC), traded Sep 14HUMABoughtKeith Anthony Jones · Director$5.6K
More on HUMA
HUMA against its rivals
No comparison pages for HUMA.